Among these vasodilatory/natriuretic agents, those particularly studied in both patients and animals with heart failure are the natriuretic peptides, primarily atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and the nitric oxide (NO) system [13,14]. The gene discussed is NPPA; the disease is heart failure.